|
There have been recent advances in the treatment of hepatocellular carcinoma (HCC). There has been a clear change in the presentation
of HCC, with an increased detection of tumors <2 cm in diameter as result of surveillance programs. In addition, the development
of effective local treatment methods has led to the necessity for the selection of base therapeutic modalities on each patient’s
characteristics. New promising image-guided therapies and new drugs, such as sorafenib, may address the enormous need
for expanded treatment options for patients with HCC. Tailored therapies are needed to improve the treatment response and, ultimately,
patient survival. Here, we review these advances in the management of HCC. (Korean J Med 77:290-297, 2009) |
PDF Links
Full text via DOI
Download Citation
